TABLE 2.
Relationship Between Activating Enhancer-Binding Protein-2β (AP2β) Staining Pattern in Stage I Non-Small Cell Lung Cancer and the Clinicopathological Features of the First Patient Seta
| AP2β Staining Pattern |
||||
|---|---|---|---|---|
| Characteristic | Total, n = 126 | Diffuse, n = 35 | Nucleolar, n = 91 | p |
| Mean age ± SD, y | 66 ± 18 | 64 ± 16 | 0.31 | |
| Sex | ||||
| Male | 59 (47) | 11 (31) | 48 (53) | 0.04 |
| Female | 67 (53) | 24 (69) | 43 (47) | |
| Smoking | ||||
| Never | 15 (12) | 8 (23) | 7 (8) | 0.03 |
| Ever | 111 (88) | 27 (77) | 84 (92) | |
| Histology | ||||
| Squamous cell carcinoma | 39 (31) | 8 (23) | 31 (34) | 0.28 |
| Adenocarcinoma | 87 (69) | 27 (77) | 60 (66) | |
| Differentiationb | ||||
| Well | 11 (9) | 7 (20) | 4 (4) | 0.01 |
| Moderate | 59 (47) | 17 (49) | 42 (46) | |
| Poor | 49 (39) | 9 (26) | 40 (44) | |
| Mean tumor size ± SD, cm | 2.7 ± 1 | 3.2 ± 1.7 | 0.24 | |
a
Data are given as no. of patients (%) unless otherwise indicated.
b
Tumor differentiation data for seven patients were unavailable.
SD, standard deviation; NS, not significant.